Sofosbuvir: The Creation of an [In]Valuable Medicine for Hepatitis C

Authors

  • Sarai Keestra Department of Global Health & Development, London School of Hygiene and Tropical Medicine

Abstract

N/A

Vol. 1 No. 6 (2021)

Downloads

Published

2021-09-29

How to Cite

Keestra, S. (2021). Sofosbuvir: The Creation of an [In]Valuable Medicine for Hepatitis C. Global Health: Annual Review, 1(6). Retrieved from https://journals.mcmaster.ca/ghar/article/view/2667

Issue

Vol. 1 No. 6 (2021): Global Health: Annual Review, Issue 6

Section

Issue 6: Innovations and Empowering People

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).